NLRP3 and attention deficit-hyperactivity disorder: Based on these findings, we hypothesized that long-term ABA treatment in the dopamine deficit model of ADHD would alleviate symptoms by modulating microglial activity, the NLRP3 inflammasome, and the E/I balance in specific brain regions.